The iShares U.S. Healthcare ETF (IYH) has an implied analyst target price of $66.34, suggesting a potential upside of 19.84% from its recent trading price of $55.36. This analysis is based on the underlying holdings within the ETF, which are expected to perform better over the next 12 months.
Among IYH’s top underlying holdings, Apellis Pharmaceuticals Inc (APLS) has a recent price of $17.69 with an average target of $36.00, indicating a 103.50% upside. Enovis Corp (ENOV) trades at $30.11 with a target price of $60.00, implying a 99.27% upside, while Repligen Corp (RGEN) is priced at $118.83 with an average target of $184.33, showing a 55.13% upside.
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| iShares U.S. Healthcare ETF | IYH | $55.36 | $66.34 | 19.84% |
| Apellis Pharmaceuticals Inc | APLS | $17.69 | $36.00 | 103.50% |
| Enovis Corp | ENOV | $30.11 | $60.00 | 99.27% |
| Repligen Corp. | RGEN | $118.83 | $184.33 | 55.13% |
